Literature DB >> 22321657

The prevalence of low bone mineral density in Brazilian patients with systemic lupus erythematosus and its relationship with the disease damage index and other associated factors.

Maria Isabel Dutra Souto1, Alycia Coelho, Carina Guo, Laura Maria C Mendonça, Maria Fernanda M C Pinheiro, Jose Angelo S Papi, Maria Lucia F Farias.   

Abstract

The aim of this study was to examine the prevalence of osteoporosis, osteopenia, and bone mineral density (BMD) less than the expected range based on age in patients with systemic lupus erythematosus (SLE) in a tropical region of Brazil and the relationship between reduced BMD and several associated factors, especially the SLE disease damage index (SDI). We scored 159 patients with creatinine clearance of 60 mL/min or more for SDI, which was modified by excluding the osteoporosis item. For postmenopausal women and men older than 50 yr, T-scores identified osteopenia (<-1.0 and >-2.5) and osteoporosis (≤-2.5). For all patients, a Z-score of -2.0 or less identified BMD less than the expected range for age. Other variables that influence BMD were studied. The prevalence of osteoporosis, osteopenia, and BMD less than the expected range for age was 28%, 54%, and 29.6%, respectively. The Z-scores were significantly lower in patients with a modified SDI ≥ 1 (mean ± standard deviation [SD]=-1.45 ± 1.18) compared with patients with a modified SDI=0 (mean ± SD=-0.94 ± 1.01; p=0.01). The lowest Z-score had a significant association with postmenopausal status (p=0.038) and significant correlations with the duration of glucocorticoid (GC) usage (p=0.033, r=-0.17), the cumulative amount of GC (p=0.000, r=-0.28), and parathyroid hormone levels (p=0.003, r=-0.24). A multiple linear regression revealed that the modified SDI (p=0.003) and the cumulative amount of GC (p=0.006) had significant independent associations with the lowest Z-score. In conclusion, a BMD less than the expected range for age occurs frequently in Brazilian patients with SLE independent of the renal failure. The patients with greater SDIs had lower Z-scores, which suggests a direct association between chronic inflammation from disease and a reduced BMD.
Copyright © 2012 The International Society for Clinical Densitometry. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22321657     DOI: 10.1016/j.jocd.2011.12.002

Source DB:  PubMed          Journal:  J Clin Densitom        ISSN: 1094-6950            Impact factor:   2.617


  4 in total

1.  Lower P1NP serum levels: a predictive marker of bone loss after 1 year follow-up in premenopausal systemic lupus erythematosus patients.

Authors:  L P C Seguro; C B Casella; V F Caparbo; R M Oliveira; A Bonfa; E Bonfa; R M R Pereira
Journal:  Osteoporos Int       Date:  2014-08-22       Impact factor: 4.507

2.  Increased serum fibroblast growth factor-23 and decreased bone turnover in patients with systemic lupus erythematosus under treatment with cyclosporine and steroid but not steroid only.

Authors:  C-C Lai; W-S Chen; D-M Chang; Y-P Tsao; T-H Wu; C-T Chou; C-Y Tsai
Journal:  Osteoporos Int       Date:  2014-10-01       Impact factor: 4.507

3.  Transplantation of mesenchymal stem cells ameliorates secondary osteoporosis through interleukin-17-impaired functions of recipient bone marrow mesenchymal stem cells in MRL/lpr mice.

Authors:  Lan Ma; Reona Aijima; Yoshihiro Hoshino; Haruyoshi Yamaza; Erika Tomoda; Yosuke Tanaka; Soichiro Sonoda; Guangtai Song; Wei Zhao; Kazuaki Nonaka; Songtao Shi; Takayoshi Yamaza
Journal:  Stem Cell Res Ther       Date:  2015-05-27       Impact factor: 6.832

4.  Assessment of Low Bone Mineral Density in Untreated Patients with Takayasu's Arteritis.

Authors:  Lingfei Mo; Jing Wang; BoMiao Ju; Yanhua Wang; Jing Luo; Juan Tian; Lan He
Journal:  Biomed Res Int       Date:  2021-10-13       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.